Palo Alto – September 19, 2019 – Cooley was named Licensing & Collaboration Firm of the Year at the LMG Life Sciences Awards, held September 18 in New York. Partner Ivor Elrifi, chair of Cooley’s global patent practice, took home the award for New York Patent Strategy & Management Attorney of the Year for the second year in a row. In addition, partner Mika Reiner Mayer was named the California Patent Strategy & Management Attorney of the Year. Cooley also earned the Financial & Corporate Impact Deal of the Year award for its work on Goldfinch Bio’s collaboration with Gilead Sciences.
The LMG Life Sciences Awards honor firms, individuals and companies behind the most innovative and challenging life sciences work. Last year, Cooley was named LMG Life Sciences’ Corporate Firm of the Year.
With more than 40 years representing life sciences clients, Cooley has been at the forefront working alongside leading life sciences companies across the globe. Clients include both high-growth and mature companies as well as entrepreneurs, venture capitalists and financial institutions. Cooley is counsel to more than 1400 public and private life sciences companies across the globe and counsel to more than 50% of the companies on the Nasdaq Biotechnology Index.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,000+ lawyers across 15 offices in the United States, Asia and Europe.